143 related articles for article (PubMed ID: 3113148)
21. [Endocrinopathy and Leydig cell tumor in the testis].
Vaage S; Foerster A; Kirkhus B; Heilo A; Halse J; Johannesen OM
Tidsskr Nor Laegeforen; 1988 Apr; 108(12):922-4. PubMed ID: 3132746
[No Abstract] [Full Text] [Related]
22. Germinal cell aplasia: response of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone to LH/FSH-releasing hormone with histopathologic correlation.
Guay AT; Tuthill RJ; Woolf PD
Fertil Steril; 1977 Jun; 28(6):642-9. PubMed ID: 324822
[TBL] [Abstract][Full Text] [Related]
23. Elevated levels of inhibin-A and immunoreactive inhibin in aged male Wistar rats with testicular Leydig cell tumor.
Herath CB; Watanabe G; Wanzhu J; Noguchi J; Akiyama K; Kuramoto K; Groome NP; Taya K
J Androl; 2001; 22(5):838-46. PubMed ID: 11545298
[TBL] [Abstract][Full Text] [Related]
24. Reversal of long-term LH deprivation on testosterone secretion and Leydig cell volume, number and proliferation in adult rats.
Keeney DS; Sprando RL; Robaire B; Zirkin BR; Ewing LL
J Endocrinol; 1990 Oct; 127(1):47-58. PubMed ID: 2129433
[TBL] [Abstract][Full Text] [Related]
25. Leydig cell tumour of the testis with gynaecomastia and elevated oestrogen, progesterone and prolactin levels: case report.
Perez C; Novoa J; Alcañiz J; Salto L; Barcelo B
Clin Endocrinol (Oxf); 1980 Nov; 13(5):409-12. PubMed ID: 7226564
[TBL] [Abstract][Full Text] [Related]
26. Leydig cell function in patients with testicular cancer during and after chemotherapy.
Willemse PH; Sleijfer DT; Schraffordt Koops H; Pratt JJ; Sluiter WJ; Doorenbos H
Int J Androl; 1983 Dec; 6(6):497-508. PubMed ID: 6421750
[TBL] [Abstract][Full Text] [Related]
27. A hCG-secreting testicular seminoma revealed by male infertility: mechanism of hCG-evoked endocrine disturbances.
Lefebvre H; Laquerriere A; Cleret JM; Kuhn JM
Andrologia; 1993; 25(5):283-7. PubMed ID: 8250292
[TBL] [Abstract][Full Text] [Related]
28. Feminizing testicular Leydig cell tumor: hormonal profile before and after unilateral orchidectomy.
Mineur P; De Cooman S; Hustin J; Verhoeven G; De Hertogh R
J Clin Endocrinol Metab; 1987 Apr; 64(4):686-91. PubMed ID: 3818898
[TBL] [Abstract][Full Text] [Related]
29. The hormone pattern in a case of arrhenoblastoma.
Toscano V; Adamo MV; Boscherini B; Pasquino AM; Herlitzka L; Petrangeli E; Sciarra F
Eur J Pediatr; 1981 May; 136(2):203-6. PubMed ID: 6262084
[TBL] [Abstract][Full Text] [Related]
30. The influence of short photoperiod on testicular and circulating levels of testosterone precursors in the adult golden hamster.
Chandrashekar V; Bartke A
Biol Reprod; 1989 Feb; 40(2):300-6. PubMed ID: 2497806
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
32. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
33. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
Wang CF; Lasley BL; Yen SS
J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
[TBL] [Abstract][Full Text] [Related]
34. Pituitary-testicular responsiveness in male hypogonadotropic hypogonadism.
Weinstein RL; Reitz RE
J Clin Invest; 1974 Feb; 53(2):408-15. PubMed ID: 11344554
[TBL] [Abstract][Full Text] [Related]
35. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL
Horm Res; 1976; 7(1):1-10. PubMed ID: 793974
[TBL] [Abstract][Full Text] [Related]
36. Hormonal perturbations in patients with testicular cancer treated with cisplatin.
LeBlanc GA; Kantoff PW; Ng SF; Frei E; Waxman DJ
Cancer; 1992 May; 69(9):2306-10. PubMed ID: 1562977
[TBL] [Abstract][Full Text] [Related]
37. Testicular response to exogenous gonadotropins in the syndrome of feminizing testes.
Turksoy RN; Mitchell GW; Safaii HS
Fertil Steril; 1976 Jun; 27(6):670-6. PubMed ID: 945197
[TBL] [Abstract][Full Text] [Related]
38. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
39. 17 beta-hydroxysteroid dehydrogenase deficiency in malignant interstitial cell carcinoma of the testis.
Davis S; DiMartino NA; Schneider G
J Clin Endocrinol Metab; 1980 Dec; 51(6):1293-7. PubMed ID: 6449517
[TBL] [Abstract][Full Text] [Related]
40. Oestrogen secreting Leydig cell tumour and GnRH agonist in-vivo and in-vitro studies.
Kerlan V; Nahoul K; Abalain JH; Mangin P; Bercovici JP
Clin Endocrinol (Oxf); 1992 Sep; 37(3):221-6. PubMed ID: 1424204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
